Longduoduo Co LtdOTC Pink - Current Information:LDDD
- LAST PRICE5.1900
- TODAY'S CHANGE (%)-0.3100 (-5.6364%)
- Bid / Lots3.2600/ 2
- Ask / Lots25.0000/ 1
- Open / Previous Close5.1900 / 5.5000
- Day Range
- 52 Week Range
- Volume111
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LDDD |
|---|---|---|
| 01:54 ET | 111 | 5.19 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Longduoduo Co Ltd | 165.0M | 124.0x | --- |
Joint Corp | 166.5M | -11.6x | --- |
Biodesix Inc | 201.8M | -2.9x | --- |
Zomedica Corp | 117.6M | -2.1x | --- |
Cardiff Lexington Corp | 98.5M | 0.6x | --- |
Cryo-Cell International Inc | 59.4M | -6.7x | --- |
Company Information
Longduoduo Co Ltd is a company principally engaged the provision of preventive care services. The Company provides solution for chronic disease problems through non-drug treatments and prevents cardiovascular and cerebrovascular diseases in advance. The Company offers health consultation and advice to customers and sells treatment services to customers, provided by Longduoduo to customers in local cooperative medical institutions. The Company's treatment projects mainly include ozone autologous blood transfusion (immunotherapy), Xingnao Tongluo therapy, double blood purification, platelet-rich plasma (PRP) injection therapy and others. The Company's products and services are mainly used for the prevention of myocardial infarction, cerebral infarction, hemiplegia, cardiovascular and cerebrovascular diseases. The Company mainly conduct its businesses in domestic market.
Contact Information
- Headquarters
- 4-419, 2Nd Light Hospital, Ordos StreetHUHEHAOTE, INM, China 010000
- Phone
- 472-510-4980
- Fax
- ---
Executives
- Chairman of the Board, President
- Huibo Xu
- Chief Executive Officer, Director
- Hongxiao Zhou
- Chief Financial Officer
- Liping Kang
- Director
- Shan Bo
- Director
- Jiayang Ma
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $165.0M |
|---|---|
Revenue (TTM) | $7.4M |
Shares Outstanding | 30.0M |
Longduoduo Co Ltd does not pay a dividend. | |
Beta | --- |
EPS | $0.04 |
Book Value | $0.02 |
P/E Ratio | 124.0x |
Price/Sales (TTM) | 22.3 |
Price/Cash Flow (TTM) | 112.6x |
Operating Margin | 27.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
